Global Retirement Partners, LLC Athira Pharma, Inc. Transaction History
Global Retirement Partners, LLC
- $4.24 Billion
- Q3 2025
A detailed history of Global Retirement Partners, LLC transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 52 shares of ATHA stock, worth $217. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52
Previous 519
89.98%
Holding current value
$217
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ATHA
# of Institutions
53Shares Held
16.9MCall Options Held
24.1KPut Options Held
0-
Perceptive Advisors LLC New York, NY5.4MShares$22.6 Million0.07% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.23MShares$13.5 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.54MShares$6.44 Million0.0% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$6.25 Million0.55% of portfolio
-
Black Rock Inc. New York, NY676KShares$2.83 Million0.0% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $158M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...